解读牙菌瘤:拷贝数变异作为诊断签名的作用
Aobo Zhang1,2, Jianyun Zhang1,2, Xuefen Li2,3
1Department of Oral Pathology, Peking University School and Hospital of Stomatology / National Center of Stomatology / National Clinical Research Center for Oral Diseases / National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China.
Journal of Zhejiang University. Science. B
|January 1, 2025
概括
副本数变异 (CNV) 分析为牙菌瘤 (OM) 提供了可靠的诊断工具. 这项研究在大多数OM病例中发现了明显的CNV模式,有助于将其与其他牙组织区分开来.
科学领域:
- 基因组学就是基因组学.
- 口腔病理学 口腔病理学
- 分子诊断学 分子诊断
背景情况:
- 牙菌瘤 (OM) 缺乏可靠的分子标记物,使诊断复杂化.
- 副本数变异 (CNV) 检测为模两可的病例提供了客观的诊断方法.
研究的目的:
- 在OM中识别和表征不同的CNV配置文件.
- 为了比较OM CNV模式与牙乳头 (DP),牙毛囊 (DF) 和牙生纤维瘤 (OF) 的模式.
- 通过CNV分析探索OM背后的分子机制.
主要方法:
- 多区域微剖析测序用于整合形态和基因组数据.
- 分析了OM,DP,DF和OF组织的CNV概况.
- 基因和基因组的京都百科全书 (KEGG) 和基因本体学 (GO) 分析进行.
主要成果:
- 在93.75%的OM病例中,在特定染色体上发现了一致的CNV增长模式.
- 这种特定于OM的CNV模式与DP,DF和OF显著不同.
- 凯格和GO分析表明与信号传递,唾液分泌,瘤粘附,牙发育和细胞增殖的联系.
结论:
- CNV分析为OM提供了强有力的诊断线索,特别是将其与OF区分开来.
- 鉴定到的CNV模式为OM的分子病变产生提供了洞察力.
- 这种基因组方法增强了对口腔瘤的诊断客观性.
相关概念视频
Comparing Copy Number Variations and SNPs
16.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
16.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K


